Search - tctmd.com

Displaying 621 - 640 of 1417

Sort: Relevancy | Date

News Opinion Editor's Corner

My Takeaways From AHA 2015

November 18, 2015

News Daily News

La Complejidad de la ECA No Influye en la Dominación de los SLF Nuevos vs. Viejos

November 16, 2015

News Daily News

CAD复杂性不影响新一代DES相对于较早DES的优越性

November 16, 2015

News Daily News

CAD Complexity Does Not Affect Dominance of Newer vs Older DES

November 16, 2015

News Industry News

Leviticus Cardio Achieves Successful Transcutaneous Coplanar Energy Transfer in Chronic Animal Model

November 15, 2015

News Conference News AHA 2015

Degree of LDL Cholesterol-Lowering on High-Intensity Rosuvastatin Determines Clinical Impact

November 12, 2015

News Conference News AHA 2015

PROMISE Analyses: Coronary CTA May Hold Some Benefits for Patients With Suspected CAD

November 10, 2015

News Daily News

¿Derroche o Garantía? El Gasto Médico se asocia a Menos Reclamaciones por Mala Praxis

November 05, 2015

News Daily News

浪费还是必要的？医生花费与更少的医疗事故索赔有联系

November 05, 2015

News Daily News

Wasteful or Warranted? Physician Spending Tied to Fewer Malpractice Claims

November 05, 2015

Statin Pretreatment Prior to PCI: Are the Effects Real?

Presentation TCT 2015

Statin Pretreatment Prior to PCI: Are the Effects Real?

Presenter: Frederick Feit, C. Michael Gibson, Germano Di Sciascio

October 15, 2015

Cilostazol: When to Consider (and Is the Data Robust?)

Presentation TCT 2015

Cilostazol: When to Consider (and Is the Data Robust?)

Presenter: Frederick Feit, C. Michael Gibson

October 15, 2015

Neurological Complications of TEVAR: Prevention and Management

Presentation TCT 2015

Neurological Complications of TEVAR: Prevention and Management

Presenter: Wilson Y. Szeto, Rodney White, Michael D. Dake

October 15, 2015

The PCSK9 Inhibitor Revolution

Presentation TCT 2015

The PCSK9 Inhibitor Revolution

Presenter: Frederick Feit, C. Michael Gibson, Norman E. Lepor

October 15, 2015

Is There a Role for Oral Anticoagulants After PCI?

Presentation TCT 2015

Is There a Role for Oral Anticoagulants After PCI?

Presenter: Eric R. Bates, Neal S. Kleiman, C. Michael Gibson

October 15, 2015

Pros and Cons of CABG vs PCI in the Diabetic Patient With Multivessel Disease: Insights From Randomized Trials

Presentation TCT 2015

Pros and Cons of CABG vs PCI in the Diabetic Patient With Multivessel Disease: Insights From Randomized Trials

Presenter: Frederick Feit, David J. Maron, Michael E. Farkouh

October 15, 2015

Considerations Regarding Renal Function in the Patient With Atrial Fibrillation

Presentation TCT 2015

Considerations Regarding Renal Function in the Patient With Atrial Fibrillation

Presenter: Gerhard C. Schuler, C. Michael Gibson

October 14, 2015

Key Elements of BRS Nonclinical Testing to Support IDE Approval

Presentation TCT 2015

Key Elements of BRS Nonclinical Testing to Support IDE Approval

Presenter: Andrew Farb, Gregg W. Stone, Michael C. John

October 14, 2015

Controversial Viewpoints: Clinical Trial Designs for Transcatheter Repair/Replacement of Functional MR COUNTERPOINT: The COAPT Bar Is Set Too High and Alternative Trial Designs Are Needed!

Presentation TCT 2015

Controversial Viewpoints: Clinical Trial Designs for Transcatheter Repair/Replacement of Functional MR COUNTERPOINT: The COAPT Bar Is Set Too High and Alternative Trial Designs Are Needed!

Presenter: John C Laschinger, Michael J. Mack, Neil E. Moat

October 14, 2015

Controversial Viewpoints: Clinical Trial Designs for Transcatheter Repair/Replacement of Functional MR POINT: Defending MVARC and COAPT as the Clear Path to Approval

Presentation TCT 2015

Controversial Viewpoints: Clinical Trial Designs for Transcatheter Repair/Replacement of Functional MR POINT: Defending MVARC and COAPT as the Clear Path to Approval

Presenter: John C Laschinger, Michael J. Mack

October 14, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.